Abstract | PURPOSE: METHODS: Between 2002 and 2019, 254 HBV-HCC patients underwent LDLT. The patients were divided into two groups after the application of the exclusion criteria: HBV-HCC (Group B; n = 163) and HBV-HDV-HCC (Group D; n = 31). First, the B and D groups were compared in terms of demographic and clinical parameters. Second, patients with (n = 16) and without (n = 178) post-transplant HBV-HCC co-recurrences were grouped and compared in terms of the same parameters. RESULTS: Although the risk of HBV-HCC co-recurrence in group D was 4.99-fold higher than in group B, the risk of HBV recurrence alone in group D was 12.5-fold lower than in group B. The AFP (OR = 4.4), Milan criteria (beyond; OR = 18.8), and HDV (OR = 8.1) were identified as the independent risk factors affecting post-transplant HBV-HCC co-recurrence. The Milan criteria (OR = 2.1) and HBV-HCC co-recurrence (OR = 10.9) were identified as the risk factors affecting post-transplant mortality. HBV-HCC co-recurrence developed in 26.5% of patients in Group B and 100% in Group D (OR = 40; p = 0.001). HCC recurrence alone developed in 10% of patients without HBV recurrence in group B and 0% of patients without HBV recurrence in group D (OR = 5.7). CONCLUSION: This study showed that the risk of HBV recurrence alone was reduced by 12.5-fold in the presence of HDV; however, the HCC recurrence occurred in all patients with HDV when HBV recurrence developed.
|
Authors | Adil Baskiran, Sami Akbulut, Tevfik Tolga Sahin, Cemalettin Koc, Serdar Karakas, Volkan Ince, Cihan Yurdaydin, Sezai Yilmaz |
Journal | Hepatology international
(Hepatol Int)
Vol. 14
Issue 5
Pg. 869-880
(Sep 2020)
ISSN: 1936-0541 [Electronic] United States |
PMID | 32895876
(Publication Type: Journal Article)
|
Topics |
- Adult
- Carcinoma, Hepatocellular
(epidemiology, pathology, surgery, virology)
- Coinfection
(epidemiology, virology)
- Female
- Hepatitis B virus
(isolation & purification, pathogenicity)
- Hepatitis B, Chronic
(complications, diagnosis, epidemiology, physiopathology)
- Hepatitis D
(complications, diagnosis)
- Hepatitis Delta Virus
(isolation & purification)
- Humans
- Liver Neoplasms
(epidemiology, pathology, surgery, virology)
- Liver Transplantation
(adverse effects, methods)
- Male
- Postoperative Complications
(diagnosis, physiopathology, virology)
- Recurrence
- Risk Assessment
- Risk Factors
- Turkey
(epidemiology)
|